166 related articles for article (PubMed ID: 17456760)
1. Loss of fibulin-2 expression is associated with breast cancer progression.
Yi CH; Smith DJ; West WW; Hollingsworth MA
Am J Pathol; 2007 May; 170(5):1535-45. PubMed ID: 17456760
[TBL] [Abstract][Full Text] [Related]
2. Expression of extracellular matrix proteins fibulin-1 and fibulin-2 by human corneal fibroblasts.
Ducros E; Berthaut A; Mirshahi P; Lemarchand S; Soria J; Legeais JM; Mirshahi M
Curr Eye Res; 2007 Jun; 32(6):481-90. PubMed ID: 17612964
[TBL] [Abstract][Full Text] [Related]
3. Fibulin-1 is down-regulated through promoter hypermethylation and suppresses renal cell carcinoma progression.
Xiao W; Wang J; Li H; Guan W; Xia D; Yu G; Xiao H; Lang B; Ma X; Liu J; Zhang X; Ye Z; Xu H
J Urol; 2013 Jul; 190(1):291-301. PubMed ID: 23391467
[TBL] [Abstract][Full Text] [Related]
4. Fibulin-2 is a driver of malignant progression in lung adenocarcinoma.
Baird BN; Schliekelman MJ; Ahn YH; Chen Y; Roybal JD; Gill BJ; Mishra DK; Erez B; O'Reilly M; Yang Y; Patel M; Liu X; Thilaganathan N; Larina IV; Dickinson ME; West JL; Gibbons DL; Liu DD; Kim MP; Hicks JM; Wistuba II; Hanash SM; Kurie JM
PLoS One; 2013; 8(6):e67054. PubMed ID: 23785517
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of several fibulin genes in prostate cancer.
Wlazlinski A; Engers R; Hoffmann MJ; Hader C; Jung V; Müller M; Schulz WA
Prostate; 2007 Dec; 67(16):1770-80. PubMed ID: 17929269
[TBL] [Abstract][Full Text] [Related]
6. JAM-A expression positively correlates with poor prognosis in breast cancer patients.
McSherry EA; McGee SF; Jirstrom K; Doyle EM; Brennan DJ; Landberg G; Dervan PA; Hopkins AM; Gallagher WM
Int J Cancer; 2009 Sep; 125(6):1343-51. PubMed ID: 19533747
[TBL] [Abstract][Full Text] [Related]
7. p38 MAPK down-regulates fibulin 3 expression through methylation of gene regulatory sequences: role in migration and invasion.
Arechederra M; Priego N; Vázquez-Carballo A; Sequera C; Gutiérrez-Uzquiza Á; Cerezo-Guisado MI; Ortiz-Rivero S; Roncero C; Cuenda A; Guerrero C; Porras A
J Biol Chem; 2015 Feb; 290(7):4383-97. PubMed ID: 25548290
[TBL] [Abstract][Full Text] [Related]
8. Suppression of anchorage-independent growth and matrigel invasion and delayed tumor formation by elevated expression of fibulin-1D in human fibrosarcoma-derived cell lines.
Qing J; Maher VM; Tran H; Argraves WS; Dunstan RW; McCormick JJ
Oncogene; 1997 Oct; 15(18):2159-68. PubMed ID: 9393974
[TBL] [Abstract][Full Text] [Related]
9. Fibulin-1 interacts with Sex Hormone Binding Globulin and is linked to less aggressive estrogen-dependent breast cancers.
Marano F; Zunino V; Frairia R; Arvat E; Castellano I; Bosco O; Catalano MG; Fortunati N
Life Sci; 2018 Aug; 207():372-380. PubMed ID: 29940241
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression and altered processing of fibulin-1 protein in human breast cancer.
Greene LM; Twal WO; Duffy MJ; McDermott EW; Hill AD; O'Higgins NJ; McCann AH; Dervan PA; Argraves WS; Gallagher WM
Br J Cancer; 2003 Mar; 88(6):871-8. PubMed ID: 12644824
[TBL] [Abstract][Full Text] [Related]
11. GROalpha is highly expressed in adenocarcinoma of the colon and down-regulates fibulin-1.
Wen Y; Giardina SF; Hamming D; Greenman J; Zachariah E; Bacolod MD; Liu H; Shia J; Amenta PS; Barany F; Paty P; Gerald W; Notterman D
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5951-9. PubMed ID: 17062666
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
[TBL] [Abstract][Full Text] [Related]
13. Activation of TGF-β1 Pathway by SCUBE3 Regulates TWIST1 Expression and Promotes Breast Cancer Progression.
Yang X; Hu J; Shi C; Dai J
Cancer Biother Radiopharm; 2020 Mar; 35(2):120-128. PubMed ID: 31742430
[No Abstract] [Full Text] [Related]
14. Identification of breast cancer-restricted antigens by antibody screening of SKBR3 cDNA library using a preselected patient's serum.
Forti S; Scanlan MJ; Invernizzi A; Castiglioni F; Pupa S; Agresti R; Fontanelli R; Morelli D; Old LJ; Pupa SM; Ménard S
Breast Cancer Res Treat; 2002 Jun; 73(3):245-56. PubMed ID: 12160330
[TBL] [Abstract][Full Text] [Related]
15. Estradiol and fibulin-1 inhibit motility of human ovarian- and breast-cancer cells induced by fibronectin.
Hayashido Y; Lucas A; Rougeot C; Godyna S; Argraves WS; Rochefort H
Int J Cancer; 1998 Feb; 75(4):654-8. PubMed ID: 9466671
[TBL] [Abstract][Full Text] [Related]
16. Characterization and functional analysis of osteoblast-derived fibulins in the human hematopoietic stem cell niche.
Hergeth SP; Aicher WK; Essl M; Schreiber TD; Sasaki T; Klein G
Exp Hematol; 2008 Aug; 36(8):1022-34. PubMed ID: 18468769
[TBL] [Abstract][Full Text] [Related]
17. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
18. Fibulin-5 is a tumour suppressor inhibiting cell migration and invasion in ovarian cancer.
Heo JH; Song JY; Jeong JY; Kim G; Kim TH; Kang H; Kwon AY; An HJ
J Clin Pathol; 2016 Feb; 69(2):109-16. PubMed ID: 26251522
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer.
Cohen B; Shimizu M; Izrailit J; Ng NF; Buchman Y; Pan JG; Dering J; Reedijk M
Breast Cancer Res Treat; 2010 Aug; 123(1):113-24. PubMed ID: 19915977
[TBL] [Abstract][Full Text] [Related]
20. Estrogen induction and overexpression of fibulin-1C mRNA in ovarian cancer cells.
Moll F; Katsaros D; Lazennec G; Hellio N; Roger P; Giacalone PL; Chalbos D; Maudelonde T; Rochefort H; Pujol P
Oncogene; 2002 Feb; 21(7):1097-107. PubMed ID: 11850827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
